NeoGenomics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +14.6% | +144.6% | -1.6% | +15.2% | +47.7% | +8.7% | +9.0% | +5.2% | +16.1% | +11.6% | +10.1% | |
| – | +20.9% | +138.6% | +3.4% | +8.1% | +41.8% | +22.0% | +15.0% | +8.3% | +7.8% | +6.8% | +20.1% | |
| – | +7.5% | +152.3% | -7.6% | +24.8% | +54.7% | -5.6% | +0.6% | +0.4% | +30.2% | +18.6% | -2.6% | |
| – | +56.1% | +10.7% | -21.8% | -17.5% | +182.8% | -3.0% | +165.8% | +38.6% | -9.9% | +14.1% | +19.0% | |
| – | +41.3% | +90.1% | +38.8% | -4.4% | +50.9% | +12.3% | +53.9% | -4.9% | -0.7% | +8.0% | +21.0% | |
| – | +28.3% | +94.3% | +3.2% | +18.3% | +56.8% | +8.7% | +53.0% | +13.0% | +2.0% | +8.5% | -8.8% | |
| – | -354.1% | – | +12.7% | +246.0% | +29.5% | -207.6% | – | – | – | – | – | |
| – | -8.1% | +1,070.7% | -44.6% | +12.5% | -40.4% | +89.0% | +17.1% | -7.8% | -8.9% | -4.2% | -43.3% | |
| – | -448.3% | – | – | – | -4.7% | -485.6% | – | – | – | – | – | |
| – | -1,344.6% | – | – | – | -468.3% | – | – | – | – | – | – | |
| – | -323.9% | – | – | – | +203.3% | -47.9% | -300.1% | – | – | – | – | |
| – | -55.4% | +623.2% | +4.7% | +19.7% | +18.4% | -7.4% | +33.4% | -277.1% | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.